{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:53:46Z","timestamp":1768092826925,"version":"3.49.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005544","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000}}],"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T00:00:00Z","timestamp":1492128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Children\u2019s Investment Fund Foundation"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005544","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T13:34:10Z","timestamp":1492176850000},"page":"e0005544","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2496-9620","authenticated-orcid":true,"given":"Ramzi A.","family":"Alsallaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-7888","authenticated-orcid":true,"given":"David","family":"Gurarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martial","family":"Ndeffo Mbah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Galvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-9270","authenticated-orcid":true,"given":"Charles","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,14]]},"reference":[{"key":"ref1","unstructured":"WHO | Schistosomiasis. In: WHO [Internet]. [cited 22 Mar 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/<\/ext-link>"},{"key":"ref2","unstructured":"WHO | Preventive chemotherapy in human helminthiasis [Internet]. [cited 24 May 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/43545\/1\/9241547103_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/43545\/1\/9241547103_eng.pdf<\/ext-link>"},{"key":"ref3","unstructured":"Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis\u2014Full Text View\u2014ClinicalTrials.gov [Internet]. [cited 23 Mar 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01154049\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01154049<\/ext-link>"},{"key":"ref4","unstructured":"Efficacy of Vaccine Sh28GST in Association With Praziquantel (PZQ) for Prevention of Clinical Recurrences of Schistosoma Haematobium Pathology\u2014Full Text View\u2014ClinicalTrials.gov [Internet]. [cited 23 Mar 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00870649\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00870649<\/ext-link>"},{"key":"ref5","unstructured":"A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2\/Alhydrogel With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults\u2014Full Text View\u2014ClinicalTrials.gov [Internet]. [cited 23 Mar 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02337855\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02337855<\/ext-link>"},{"key":"ref6","unstructured":"Phase 1 Clinical Trial of Sm-TSP-2 Schistosomiasis Vaccine Begins | Sabin [Internet]. [cited 5 Apr 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sabin.org\/updates\/pressreleases\/phase-1-clinical-trial-sm-tsp-2-schistosomiasis-vaccine-begins\" xlink:type=\"simple\">http:\/\/www.sabin.org\/updates\/pressreleases\/phase-1-clinical-trial-sm-tsp-2-schistosomiasis-vaccine-begins<\/ext-link>"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-015-1144-3","article-title":"Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa","volume":"8","author":"D Gurarie","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1017\/S0031182010000867","article-title":"A new approach to modelling schistosomiasis transmission based on stratified worm burden","volume":"137","author":"D Gurarie","year":"2010","journal-title":"Parasitology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e115875","DOI":"10.1371\/journal.pone.0115875","article-title":"Population biology of Schistosoma mating, aggregation, and transmission breakpoints: more reliable model analysis for the end-game in communities at risk","volume":"9","author":"D Gurarie","year":"2014","journal-title":"PloS One"},{"key":"ref10","first-page":"369","article-title":"Symbiose, parasitisme et \u00e9volution (\u00e9tude math\u00e9matique)","volume":"22","author":"VA Kostizin","year":"1978","journal-title":"Hermann Paris 1934"},{"key":"ref11","unstructured":"Government of Kenya. National Council for Population and Development (NCPD), Central Bureau of Statistics (CBS) (Office of the Vice President and Ministry of Planning and National Development [Kenya]), and Macro International Inc (MI). 1999. Kenya Demographic and Health Survey (KDHS) 1998. Calverton, Maryland; 1998."},{"key":"ref12","unstructured":"Government of Kenya. Central Bureau of Statistics (CBS), Kenya Ministry of Health (MOH), and ORC Macro. 2004. Kenya Demographic and Health Survey (KDHS) 2003. Calverton, Maryland; 2003."},{"key":"ref13","unstructured":"Government of Kenya. National Bureau of Statistics (KNBS) and ICF Macro 2010. Kenya Demographic and Health Survey (KDHS) 2008\u201309. Calverton, Maryland; 2009."},{"key":"ref14","first-page":"493","article-title":"Herd immunity to helminth infection and implications for parasite control","volume":"315","author":"RM Anderson","year":"1985","journal-title":"Herd immunity to helminth infection and implications for parasite control"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0035-9203(90)90278-M","article-title":"Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya","volume":"84","author":"RF Sturrock","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever?","volume":"195","author":"D Cioli","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"ref17","unstructured":"WHO. Schistosomiasis: progress report 2001\u20132011, strategic plan 2012\u20132020 [Internet]. 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/handle\/10665\/78074\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/handle\/10665\/78074<\/ext-link>"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"20130435","DOI":"10.1098\/rstb.2013.0435","article-title":"The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths","volume":"369","author":"R Anderson","year":"2014","journal-title":"Phil Trans R Soc B"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005544","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:15:51Z","timestamp":1540199751000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005544"}},"subtitle":[],"editor":[{"given":"Darren J.","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005544","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005544","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]}}}